Manual Diaphragmatic Release on Ventilatory Functions in Women With Rheumatoid Arthritis
- Conditions
- Rheumatic ArthritisLung Function
- Registration Number
- NCT06716008
- Lead Sponsor
- Middle East University
- Brief Summary
Evaluate the effect of manual diaphragmatic release on ventilatory functions in women with rheumatoid arthritis
- Detailed Description
Sixty women with rheumatoid arthritis will be sourced from the rheumatology outpatient clinic at Tanta University hospitals in Egypt, with referrals from rheumatologists. Patients will be randomly assigned into two groups.
The study group will include 30 women participating in manual diaphragmatic release plus aerobic training for 12 weeks while the control group will include 30 women participating in aerobic training only for 12 weeks. At baseline and poststudy, the following outcomes will be assessed:
1. Ventilatory functions (Forced vital capacity and total lung capacity).
2. Functional capacity using modified Bruce treadmill incremental exercise test (Maximal oxygen consumption estimation).
3. Quality of life (Short form health survey).
Recruitment & Eligibility
- Status
- NOT_YET_RECRUITING
- Sex
- Female
- Target Recruitment
- 60
- All women will have rheumatoid arthritis for more than 2 years with low-to-moderate disease activity.
- Normal to mildly restrictive lung pattern.
- Their ages will be ranged from 40 to 60 years old.
- Their body mass index will be less than 30 Kg/m2.
- Chronic chest diseases.
- Recent parenteral steroid administration.
- Cardiovascular disorders (coronary heart disease, heart failure, cardiac arrhythmia, peripheral arterial disease, uncontrolled hypertension).
- Smokers.
- Joint surgery (in the preceding 6 months).
- Musculoskeletal/ neurological limitations to exercise.
- Pregnancy.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method Ventilatory function At baseline and 12 weeks Ventilatory function parameters, including forced vital capacity and forced expiratory volume in the first second will be measured by experienced technicians at baseline and after 12 weeks in all groups using the Medgraphics pulmonary function testing system (Breezesuite Ultima PFX, Milano, Italy) in strict adherence to the guidelines outlined in the user manual.
- Secondary Outcome Measures
Name Time Method Functional capacity At baseline and after 12 weeks Cardiopulmonary exercise test will be conducted for all women at baseline and post-study based on the guidelines set by the American College of Sports Medicine to determine maximal oxygen consumption for each women.
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.